Home » Lannett Receives FDA Approval for Doxycycline Tablets
Lannett Receives FDA Approval for Doxycycline Tablets
Lannett Company Inc, a manufacturer of generic pharmaceuticals, said that it has received approvals from the US Food and Drug Administration (FDA) for its Abbreviated New Drug Applications (ANDAs) for Doxycycline Tablets, 75 mg and 150 mg.
TradingMarkets
TradingMarkets
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May